PPPeter Potgieter
Peter Potgieter
*This is an algorithmically generated author record based on publicly available information.
Peter Potgieter has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Nicholls
Pharmaceutical Consulting, Burlingame, CA, United States
1 shared publication - Brett Haumann
Theravance Biopharma UK, Limited, London, United Kingdom
1 shared publication - Christopher N. Barnes
Theravance Biopharma US, Inc., South San Francisco, 901 Gateway Boulevard, CA, 94080, USA
1 shared publication - Dave Singh
Manchester University NHS Foundation Trust, University of Manchester, Manchester, United Kingdom
1 shared publication - David L. Bourdet
Theravance Biopharma US, Inc., South San Francisco, USA
1 shared publication - Dean Quinn
P3 Research, 121 Adelaide Road, Mount Cook, Wellington, New Zealand
1 shared publication
Latest Publications
- Open Access
- 1 February 2018
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 48, 71-79
Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies
- 1 February 2018
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 48, 71-79
Open AccessPharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies